Literature DB >> 19918135

Childhood bacterial respiratory diseases: past, present, and future.

Hanna Nohynek1, Shabir Madhi, Carlos G Grijalva.   

Abstract

Pneumonia is the most serious acute respiratory infection and is caused by numerous etiologic agents, bacteria and viruses. Severe pneumonia is a major challenge to survival of children globally. In this article we examine the causes of global childhood mortality, and the distribution of childhood pneumonia mortality and morbidity, as well as the risk factors that affect pneumonia incidence. Although major bacterial and viral respiratory infections, such as diphtheria, measles, Haemophilus influenzae type b (Hib), and pneumococcal infections, are now preventable through vaccination, bacterial pneumonia, including severe pneumonia (those that require hospitalization), still remain a public health challenge in both resource-poor and wealthy countries. We therefore, review the published literature on the available vaccines and their potential effectiveness in further reducing the burden of childhood bacterial respiratory diseases. There is a need to conduct further epidemiologic studies for identifying the disease burden and for urgent implementation of proven cost-effective interventions. These interventions are a necessary part of public health actions to reduce childhood mortality, a major Millennium Development Goal. The role of vaccines in this regard is critical, as they represent a rapid and feasible intervention with an early and sustained impact.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19918135     DOI: 10.1097/INF.0b013e3181b6d800

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  6 in total

1.  Histopathologic evaluation of lung and extrapulmonary tissues show sex differences in Klebsiella pneumoniae - infected mice under different exposure conditions.

Authors:  Anatoly N Mikerov; Timothy K Cooper; Guirong Wang; Sanmei Hu; Todd M Umstead; David S Phelps; Joanna Floros
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2011-09-06

2.  The data management of a phase III efficacy trial of an 11-valent pneumococcal conjugate vaccine and related satellite studies conducted in the Philippines.

Authors:  Diozele Hazel M Sanvictores; Marilla G Lucero; Hanna Nohynek; Veronica L Tallo; Antti Tanskanen; Leilani T Nillos; Gail Williams
Journal:  BMC Res Notes       Date:  2012-06-07

3.  Early acquisition and high nasopharyngeal co-colonisation by Streptococcus pneumoniae and three respiratory pathogens amongst Gambian new-borns and infants.

Authors:  Brenda A Kwambana; Michael R Barer; Christian Bottomley; Richard A Adegbola; Martin Antonio
Journal:  BMC Infect Dis       Date:  2011-06-20       Impact factor: 3.090

4.  Epidemiology and clinical characteristics of acute respiratory tract infections among hospitalized infants and young children in Chengdu, West China, 2009-2014.

Authors:  Jiayi Chen; Pengwei Hu; Tao Zhou; Tianli Zheng; Lingxu Zhou; Chunping Jiang; Xiaofang Pei
Journal:  BMC Pediatr       Date:  2018-07-05       Impact factor: 2.125

Review 5.  Vaccination against Paediatric Respiratory Pathogens.

Authors:  Sonia Bianchini; Alberto Argentiero; Barbara Camilloni; Ettore Silvestri; Anna Alunno; Susanna Esposito
Journal:  Vaccines (Basel)       Date:  2019-11-01

6.  Predicting severe pneumonia in the emergency department: a global study of the Pediatric Emergency Research Networks (PERN)-study protocol.

Authors:  Todd Adam Florin; Daniel Joseph Tancredi; Lilliam Ambroggio; Franz E Babl; Stuart R Dalziel; Michelle Eckerle; Santiago Mintegi; Mark Neuman; Amy C Plint; Nathan Kuppermann
Journal:  BMJ Open       Date:  2020-12-02       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.